annual operating profit:
-$176.88M+$105.29M(+37.31%)Summary
- As of today (May 29, 2025), ALNY annual operating income is -$176.88 million, with the most recent change of +$105.29 million (+37.31%) on December 31, 2024.
- During the last 3 years, ALNY annual operating profit has risen by +$531.77 million (+75.04%).
- ALNY annual operating profit is now -4089.60% below its all-time high of -$4.22 million, reached on December 31, 2002.
Performance
ALNY Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
$18.08M+$123.24M(+117.19%)Summary
- As of today (May 29, 2025), ALNY quarterly operating income is $18.08 million, with the most recent change of +$123.24 million (+117.19%) on March 31, 2025.
- Over the past year, ALNY quarterly operating profit has increased by +$61.51 million (+141.62%).
- ALNY quarterly operating profit is now -91.55% below its all-time high of $213.87 million, reached on September 30, 2023.
Performance
ALNY quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$115.37M+$61.51M(+34.78%)Summary
- As of today (May 29, 2025), ALNY TTM operating income is -$115.37 million, with the most recent change of +$61.51 million (+34.78%) on March 31, 2025.
- Over the past year, ALNY TTM operating profit has increased by +$60.43 million (+34.37%).
- ALNY TTM operating profit is now -212.40% below its all-time high of $102.64 million, reached on June 30, 2024.
Performance
ALNY TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
ALNY Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.3% | +141.6% | +34.4% |
| 3 y3 years | +75.0% | +112.3% | +82.8% |
| 5 y5 years | +81.2% | +108.6% | +88.0% |
ALNY Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +77.5% | -91.5% | +107.0% | -212.4% | +86.0% |
| 5 y | 5-year | at high | +81.2% | -91.5% | +107.0% | -212.4% | +88.0% |
| alltime | all time | -4089.6% | +81.2% | -91.5% | +106.1% | -212.4% | +88.0% |
ALNY Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $18.08M(-117.2%) | -$115.37M(-34.8%) |
| Dec 2024 | -$176.88M(-37.3%) | -$105.16M(+36.7%) | -$176.88M(-6.0%) |
| Sep 2024 | - | -$76.91M(-258.2%) | -$188.13M(-283.3%) |
| Jun 2024 | - | $48.61M(-211.9%) | $102.64M(-158.4%) |
| Mar 2024 | - | -$43.44M(-62.7%) | -$175.80M(-37.7%) |
| Dec 2023 | -$282.18M(-64.1%) | -$116.40M(-154.4%) | -$282.18M(-20.4%) |
| Sep 2023 | - | $213.87M(-193.1%) | -$354.38M(-57.1%) |
| Jun 2023 | - | -$229.83M(+53.4%) | -$826.29M(+4.8%) |
| Mar 2023 | - | -$149.81M(-20.6%) | -$788.15M(+0.4%) |
| Dec 2022 | -$785.07M(+10.8%) | -$188.61M(-26.9%) | -$785.07M(-0.8%) |
| Sep 2022 | - | -$258.04M(+34.6%) | -$791.02M(+10.7%) |
| Jun 2022 | - | -$191.69M(+30.6%) | -$714.66M(+6.8%) |
| Mar 2022 | - | -$146.73M(-24.6%) | -$669.13M(-5.6%) |
| Dec 2021 | -$708.65M(-14.5%) | -$194.56M(+7.1%) | -$708.65M(+0.0%) |
| Sep 2021 | - | -$181.68M(+24.3%) | -$708.31M(-5.8%) |
| Jun 2021 | - | -$146.16M(-21.5%) | -$751.84M(-6.6%) |
| Mar 2021 | - | -$186.25M(-4.1%) | -$804.53M(-2.9%) |
| Dec 2020 | -$828.44M(-11.8%) | -$194.22M(-13.8%) | -$828.44M(-11.1%) |
| Sep 2020 | - | -$225.20M(+13.2%) | -$932.29M(+1.0%) |
| Jun 2020 | - | -$198.86M(-5.4%) | -$923.39M(-3.9%) |
| Mar 2020 | - | -$210.16M(-29.5%) | -$960.80M(+2.3%) |
| Dec 2019 | -$939.43M(+15.3%) | -$298.07M(+37.8%) | -$939.43M(+9.0%) |
| Sep 2019 | - | -$216.30M(-8.5%) | -$861.71M(-4.3%) |
| Jun 2019 | - | -$236.27M(+25.2%) | -$899.97M(+5.1%) |
| Mar 2019 | - | -$188.79M(-14.3%) | -$856.06M(+5.1%) |
| Dec 2018 | -$814.67M(+62.9%) | -$220.36M(-13.4%) | -$814.67M(+9.9%) |
| Sep 2018 | - | -$254.56M(+32.3%) | -$741.62M(+21.0%) |
| Jun 2018 | - | -$192.35M(+30.5%) | -$612.86M(+13.3%) |
| Mar 2018 | - | -$147.41M(+0.1%) | -$540.98M(+8.2%) |
| Dec 2017 | -$500.09M(+17.8%) | -$147.30M(+17.1%) | -$500.09M(+6.8%) |
| Sep 2017 | - | -$125.80M(+4.4%) | -$468.22M(+4.3%) |
| Jun 2017 | - | -$120.47M(+13.1%) | -$449.09M(+6.7%) |
| Mar 2017 | - | -$106.51M(-7.7%) | -$421.07M(-0.8%) |
| Dec 2016 | -$424.59M(+43.4%) | -$115.43M(+8.2%) | -$424.59M(+5.7%) |
| Sep 2016 | - | -$106.68M(+15.4%) | -$401.67M(+7.6%) |
| Jun 2016 | - | -$92.45M(-16.0%) | -$373.32M(+5.5%) |
| Mar 2016 | - | -$110.03M(+18.9%) | -$353.81M(+19.5%) |
| Dec 2015 | -$296.01M(+60.7%) | -$92.51M(+18.1%) | -$296.01M(+18.8%) |
| Sep 2015 | - | -$78.33M(+7.4%) | -$249.21M(+15.3%) |
| Jun 2015 | - | -$72.94M(+39.7%) | -$216.08M(+12.5%) |
| Mar 2015 | - | -$52.22M(+14.2%) | -$192.03M(+4.2%) |
| Dec 2014 | -$184.21M(+98.2%) | -$45.71M(+1.1%) | -$184.21M(+9.6%) |
| Sep 2014 | - | -$45.20M(-7.6%) | -$168.09M(+8.4%) |
| Jun 2014 | - | -$48.90M(+10.1%) | -$155.13M(+21.6%) |
| Mar 2014 | - | -$44.41M(+50.1%) | -$127.55M(+37.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$92.94M(+46.2%) | -$29.59M(-8.2%) | -$92.94M(+7.2%) |
| Sep 2013 | - | -$32.23M(+51.2%) | -$86.70M(+19.4%) |
| Jun 2013 | - | -$21.31M(+117.4%) | -$72.62M(+14.6%) |
| Mar 2013 | - | -$9.80M(-58.0%) | -$63.37M(-0.3%) |
| Dec 2012 | -$63.57M(+16.0%) | -$23.35M(+28.7%) | -$63.57M(+18.2%) |
| Sep 2012 | - | -$18.15M(+50.4%) | -$53.80M(+11.9%) |
| Jun 2012 | - | -$12.07M(+20.7%) | -$48.09M(-2.1%) |
| Mar 2012 | - | -$10.00M(-26.4%) | -$49.14M(-10.4%) |
| Dec 2011 | -$54.82M(+25.3%) | -$13.59M(+9.2%) | -$54.82M(+2.8%) |
| Sep 2011 | - | -$12.44M(-5.2%) | -$53.31M(+7.5%) |
| Jun 2011 | - | -$13.12M(-16.3%) | -$49.60M(+3.1%) |
| Mar 2011 | - | -$15.68M(+29.8%) | -$48.11M(+10.0%) |
| Dec 2010 | -$43.74M(-9.1%) | -$12.08M(+38.4%) | -$43.74M(+10.1%) |
| Sep 2010 | - | -$8.73M(-24.9%) | -$39.73M(-2.3%) |
| Jun 2010 | - | -$11.63M(+2.8%) | -$40.65M(-21.0%) |
| Mar 2010 | - | -$11.31M(+40.1%) | -$51.44M(+6.9%) |
| Dec 2009 | -$48.11M(+72.8%) | -$8.07M(-16.4%) | -$48.11M(+0.5%) |
| Sep 2009 | - | -$9.65M(-56.9%) | -$47.85M(+15.5%) |
| Jun 2009 | - | -$22.41M(+180.9%) | -$41.44M(+30.1%) |
| Mar 2009 | - | -$7.98M(+2.1%) | -$31.86M(+14.5%) |
| Dec 2008 | -$27.84M(-70.1%) | -$7.81M(+141.6%) | -$27.84M(+21.5%) |
| Sep 2008 | - | -$3.23M(-74.8%) | -$22.91M(-67.7%) |
| Jun 2008 | - | -$12.83M(+224.3%) | -$71.02M(-2.9%) |
| Mar 2008 | - | -$3.96M(+36.8%) | -$73.14M(-21.5%) |
| Dec 2007 | -$93.18M(+135.9%) | -$2.89M(-94.4%) | -$93.18M(-7.1%) |
| Sep 2007 | - | -$51.34M(+243.3%) | -$100.28M(+74.3%) |
| Jun 2007 | - | -$14.95M(-37.7%) | -$57.54M(+7.2%) |
| Mar 2007 | - | -$23.99M(+140.2%) | -$53.70M(+35.9%) |
| Dec 2006 | -$39.50M(-9.1%) | -$9.99M(+16.1%) | -$39.50M(-11.1%) |
| Sep 2006 | - | -$8.60M(-22.5%) | -$44.43M(-4.4%) |
| Jun 2006 | - | -$11.11M(+13.4%) | -$46.49M(-0.2%) |
| Mar 2006 | - | -$9.80M(-34.3%) | -$46.59M(+7.2%) |
| Dec 2005 | -$43.47M(+34.7%) | -$14.92M(+39.8%) | -$43.47M(+27.5%) |
| Sep 2005 | - | -$10.67M(-4.8%) | -$34.09M(+14.2%) |
| Jun 2005 | - | -$11.20M(+67.7%) | -$29.84M(+16.5%) |
| Mar 2005 | - | -$6.68M(+20.8%) | -$25.61M(-20.6%) |
| Dec 2004 | -$32.26M(+57.8%) | -$5.53M(-13.9%) | -$32.26M(-31.8%) |
| Sep 2004 | - | -$6.43M(-7.9%) | -$47.31M(+15.8%) |
| Jun 2004 | - | -$6.97M(-47.7%) | -$40.84M(+14.6%) |
| Mar 2004 | - | -$13.33M(-35.2%) | -$35.65M(+51.2%) |
| Dec 2003 | -$20.45M(+384.3%) | -$20.58M(<-9900.0%) | -$23.59M(+684.6%) |
| Sep 2003 | - | $44.00K(-102.5%) | -$3.01M(-1.4%) |
| Jun 2003 | - | -$1.78M(+40.9%) | -$3.05M(+140.9%) |
| Mar 2003 | - | -$1.27M | -$1.27M |
| Dec 2002 | -$4.22M | - | - |
FAQ
- What is Alnylam Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual operating profit year-on-year change?
- What is Alnylam Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly operating profit year-on-year change?
- What is Alnylam Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals TTM operating profit year-on-year change?
What is Alnylam Pharmaceuticals annual operating income?
The current annual operating profit of ALNY is -$176.88M
What is the all time high annual operating profit for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual operating income is -$4.22M
What is Alnylam Pharmaceuticals annual operating profit year-on-year change?
Over the past year, ALNY annual operating income has changed by +$105.29M (+37.31%)
What is Alnylam Pharmaceuticals quarterly operating income?
The current quarterly operating profit of ALNY is $18.08M
What is the all time high quarterly operating profit for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly operating income is $213.87M
What is Alnylam Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, ALNY quarterly operating income has changed by +$61.51M (+141.62%)
What is Alnylam Pharmaceuticals TTM operating income?
The current TTM operating profit of ALNY is -$115.37M
What is the all time high TTM operating profit for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high TTM operating income is $102.64M
What is Alnylam Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, ALNY TTM operating income has changed by +$60.43M (+34.37%)